Thus, consistent with our modeling findings, gene expression data demonstrate an increase in OPG, rather than RANKL, in metastatic prostate cancer, as well as a positive correlation between the expression of OPG and PTHrP. Here, TNFRSF11B is linked to metastatic prostate carcinoma.